Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06558435
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-14
Brief Title:
Validation of BRACS to European Portuguese
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Translation and Validation of The Boston Residue and Clearance Scale to European Portuguese
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to translate and validate the fiberoptic endoscopic evaluation of swallowing scale The Boston Residue and Clearance Scale - BRACS to European Portuguese
Detailed Description:
The Boston Residue and Clearance Scale BRACS is a multidimensional scale developed and validated to assess the severity of residues observed during fiberoptic endoscopic evaluation of swallowing FEES
It differs from other FEES residue scales since it considers all aspects related to pharyngolaryngeal residues specifically the location amount and the patients clearance ability
The purpose of this study was to translate and cross-culturally adapt the English version of the BRACS into European Portuguese and to investigate the reliability and validity of the translated version of the scale
It differs from other FEES residue scales since it considers all aspects related to pharyngolaryngeal residues specifically the location amount and the patients clearance ability
The purpose of this study was to translate and cross-culturally adapt the English version of the BRACS into European Portuguese and to investigate the reliability and validity of the translated version of the scale
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None